Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinomaHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350101-2350101 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350101 ;PMID: 38738709Full text available |
2 |
Material Type: Article
|
![]() |
The contextual awareness, response and evaluation (CARE) diabetes project: study design for a quantitative survey of diabetes prevalence and non-communicable disease risk in Ga Mashie, Accra, GhanaGlobal health action, 2024-12, Vol.17 (1), p.2297513-2297513 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2023.2297513 ;PMID: 38323339Full text available |
3 |
Material Type: Article
|
![]() |
Timing of Chest Tube Removal Following Adult Cardiac Surgery: A Cluster Randomized Controlled TrialScandinavian cardiovascular journal : SCJ, 2024-12, Vol.58 (1), p.2294681 [Peer Reviewed Journal]EISSN: 1651-2006 ;DOI: 10.1080/14017431.2023.2294681 ;PMID: 38112193Digital Resources/Online E-Resources |
4 |
Material Type: Article
|
![]() |
Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional studyGlobal health action, 2024-12, Vol.17 (1), p.2325728-2325728 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2325728 ;PMID: 38596846Full text available |
5 |
Material Type: Article
|
![]() |
"Going vaccine hunting" : Multilevel influences on COVID-19 vaccination among racialized sexual and gender minority adults-a qualitative studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2301189-2301189 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2301189 ;PMID: 38346919Full text available |
6 |
Material Type: Article
|
![]() |
Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysisHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341454-2341454 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2341454 ;PMID: 38695296Full text available |
7 |
Material Type: Article
|
![]() |
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in GermanyJournal of medical economics, 2024-12, Vol.27 (1), p.39 [Peer Reviewed Journal]EISSN: 1941-837X ;DOI: 10.1080/13696998.2023.2290388 ;PMID: 38050685Digital Resources/Online E-Resources |
8 |
Material Type: Article
|
![]() |
Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trialHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2330770-2330770 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2330770 ;PMID: 38602539Full text available |
9 |
Material Type: Article
|
![]() |
Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in miceHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2302070-2302070 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2302070 ;PMID: 38190806Full text available |
10 |
Material Type: Article
|
![]() |
Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 yearsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2313249-2313249 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2313249 ;PMID: 38538572Full text available |
11 |
Material Type: Article
|
![]() |
Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in JordanHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2333104-2333104 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2333104 ;PMID: 38584118Full text available |
12 |
Material Type: Article
|
![]() |
Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemicHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2338953-2338953 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2338953 ;PMID: 38658178Full text available |
13 |
Material Type: Article
|
![]() |
Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2343552-2343552 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2343552 ;PMID: 38723789Full text available |
14 |
Material Type: Article
|
![]() |
Estimation of cause-specific mortality in Rakai, Uganda, using verbal autopsy 1999-2019Global health action, 2024-12, Vol.17 (1), p.2338635-2338635 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2338635 ;PMID: 38717826Full text available |
15 |
Material Type: Article
|
![]() |
Number of tetanus toxoid injections before birth and associated factors among pregnant women in low and middle income countries: Negative binomial poisson regressionHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2352905-2352905 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2352905 ;PMID: 38772729Full text available |
16 |
Material Type: Article
|
![]() |
Nonstructural barriers to adult vaccinationHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2334475-2334475 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2334475 ;PMID: 38629573Full text available |
17 |
Material Type: Article
|
![]() |
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from NigeriaHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2355036-2355036 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2355036 ;PMID: 38783606Full text available |
18 |
Material Type: Article
|
![]() |
Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported casesHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350812-2350812 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350812 ;PMID: 38752704Full text available |
19 |
Material Type: Article
|
![]() |
Effectiveness of cocoon strategy vaccination on prevention of influenza-like illness in young infantsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350090-2350090 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350090 ;PMID: 38738691Full text available |
20 |
Material Type: Article
|
![]() |
No evidence, no problem? A critical interpretive synthesis of the vulnerabilities to and experiences of sexual violence among young migrants in EuropeGlobal health action, 2024-12, Vol.17 (1), p.2340114-2340114 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2340114 ;PMID: 38651216Full text available |